Vyriad

Rochester, United States

Vyriad is a clinical stage biopharmaceutical company.

$25.0M raised

Dec 2025

Series B

Top Investors

Mayo ClinicRegeneronMirae AssetSoutheast Minnesota Capital FundHarry H. Stine

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Vyriad raised?

Vyriad has raised $25.0M in total funding. The most recent round was Series B. The last funding was announced in December 2025.

Who are Vyriad's investors?

Vyriad's investors include Mayo Clinic, Regeneron, Mirae Asset, Southeast Minnesota Capital Fund, Harry H. Stine.

Where is Vyriad headquartered?

Vyriad is headquartered in Rochester, United States.

What does Vyriad do?

Vyriad is a clinical stage biopharmaceutical company.

What stage is Vyriad at?

Vyriad is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 23, 2025.

MLA

"Vyriad — Funding & Investors." VCBacked, December 23, 2025, https://www.vcbacked.co/company/vyriad. Accessed June 4, 2026.

APA

VCBacked. (2025). Vyriad — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/vyriad

Wikipedia (cite web)

{{cite web |title=Vyriad — Funding & Investors |url=https://www.vcbacked.co/company/vyriad |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 23, 2025.